Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution

Surgery (United States)

Volumn 157, Issue 4, 2015, Pages 666-675

  Kim, Dong Hun ^a   Choi, Dong Wook ^b   Choi, Seong Ho ^b   Heo, Jin Seok ^b   Kow, Alfred Wei Chieh ^c  

^a Dankook University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMPARATIVE STUDY; EVALUATION STUDY; INTRAHEPATIC BILE DUCT; LIVER; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LIVER; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925368793     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.11.006     Document Type: Article

References (45)

1. K. Shimada, T. Sano, S. Nara, M. Esaki, Y. Sakamoto, and T. Kosuge Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement Surgery 145 2009 411 416
2. S.B. Choi, K.S. Kim, J.Y. Choi, S.W. Park, J.S. Choi, and W.J. Lee The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival Ann Surg Oncol 16 2009 3048 3056
3. S. Miwa, S. Miyagawa, A. Kobayashi, Y. Akahane, T. Nakata, and M. Mihara Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery J Gastroenterol 41 2006 893 900
4. I. Endo, M. Gonen, A.C. Yopp, K.M. Dalal, Q. Zhou, and D. Klimstra Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection Ann Surg 248 2008 84 96
5. S.D. Taylor-Robinson, G.R. Foster, S. Arora, S. Hargreaves, and H.C. Thomas Increase in primary liver cancer in the UK, 1979-94 Lancet 350 1997 1142 1143
6. S. Suzuki, T. Sakaguchi, Y. Yokoi, K. Okamoto, K. Kurachi, and Y. Tsuchiya Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma World J Surg 26 2002 687 693
7. W.F. Shen, W. Zhong, F. Xu, T. Kan, L. Geng, and F. Xie Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma World J Gastroenterol 15 2009 5976 5982
8. K. Shirabe, Y. Mano, A. Taketomi, Y. Soejima, H. Uchiyama, and S. Aishima Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index Ann Surg Oncol 17 2010 1816 1822
9. T. Nakagawa, T. Kamiyama, N. Kurauchi, M. Matsushita, K. Nakanishi, and H. Kamachi Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma World J Surg 29 2005 728 733
10. D. Cherqui, B. Tantawi, R. Alon, P. Piedbois, A. Rahmouni, and D. Dhumeaux Intrahepatic cholangiocarcinoma. Results of aggressive surgical management Arch Surg 130 1995 1073 1078
11. M. Yamamoto, K. Takasaki, and T. Yoshikawa Extended resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 1999 117 121
12. H. Lang, G.C. Sotiropoulos, N.R. Fruhauf, M. Domland, A. Paul, and E.M. Kind Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period Ann Surg 241 2005 134 143
13. B.G. Jiang, L.L. Sun, W.L. Yu, Z.H. Tang, M. Zong, and Y.J. Zhang Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma Cancer J 15 2009 257 261
14. D. Tamandl, K. Kaczirek, B. Gruenberger, C. Koelblinger, J. Maresch, and R. Jakesz Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma Br J Surg 96 2009 919 925
15. T. Uenishi, S. Kubo, O. Yamazaki, T. Yamada, Y. Sasaki, and H. Nagano Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases J Hepatobiliary Pancreat Surg 15 2008 417 422
16. M. Shimada, Y. Yamashita, S. Aishima, K. Shirabe, K. Takenaka, and K. Sugimachi Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma Br J Surg 88 2001 1463 1466
17. Y. Yamashita, A. Taketomi, K. Morita, T. Fukuhara, S. Ueda, and K. Sanefuji The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients Anticancer Res 28 2008 2353 2359
18. O. Farges, D. Fuks, Y.P. Le Treut, D. Azoulay, A. Laurent, and P. Bachellier AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group Cancer 117 2011 2170 2177
19. D. Tamandl, B. Herberger, B. Gruenberger, H. Puhalla, M. Klinger, and T. Gruenberger Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma Ann Surg Oncol 15 2008 2787 2794
20. K.Y. Paik, J.C. Jung, J.S. Heo, S.H. Choi, D.W. Choi, and Y.I. Kim What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23 2008 766 770
21. Y. Morimoto, Y. Tanaka, T. Ito, M. Nakahara, H. Nakaba, and T. Nishida Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 2003 432 440
22. M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, A. Togawa, and H. Yoshidome Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival Br J Surg 89 2002 1525 1531
23. Y.Y. Jan, C.N. Yeh, T.S. Yeh, T.L. Hwang, and M.F. Chen Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma World J Surg 29 2005 894 898
24. S.M. Weber, W.R. Jarnagin, D. Klimstra, R.P. DeMatteo, Y. Fong, and L.H. Blumgart Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes J Am Coll Surg 193 2001 384 391
25. K. Uchiyama, M. Yamamoto, H. Yamaue, S. Ariizumi, T. Aoki, and N. Kokudo Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery J Hepatobiliary Pancreat Sci 18 2011 443 452
26. M.L. Quan, and D. McCready The evolution of lymph node assessment in breast cancer J Surg Oncol 99 2009 194 198
27. R.K. Orr The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis Ann Surg Oncol 6 1999 109 116
28. C. Louis-Sylvestre, K. Clough, B. Asselain, J.R. Vilcoq, R.J. Salmon, and F. Campana Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up J Clin Oncol 22 2004 97 101
29. T. Sano, M. Sasako, S. Yamamoto, A. Nashimoto, A. Kurita, and M. Hiratsuka Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501 J Clin Oncol 22 2004 2767 2773
30. E. de Bree, V. Charalampakis, J. Melissas, and D.D. Tsiftsis The extent of lymph node dissection for gastric cancer: a critical appraisal J Surg Oncol 102 2010 552 562
31. L.P. Chen, C. Li, C. Wang, T.F. Wen, L.N. Yan, and B. Li Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy Hepatogastroenterology 59 2012 1765 1768
32. G. Ercolani, G. Vetrone, G.L. Grazi, O. Aramaki, M. Cescon, and M. Ravaioli Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival Ann Surg 252 2010 107 114
33. O. Hyder, I. Hatzaras, G.C. Sotiropoulos, A. Paul, S. Alexandrescu, and H. Marques Recurrence after operative management of intrahepatic cholangiocarcinoma Surgery 153 2013 811 818
34. M. Yamamoto, K. Takasaki, T. Otsubo, H. Katsuragawa, and S. Katagiri Recurrence after surgical resection of intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 8 2001 154 157
35. M.S. Park, D.K. Lee, M.J. Kim, W.J. Lee, D.S. Yoon, and S.J. Lee Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma J Comput Assist Tomogr 30 2006 362 367
36. V. Vilgrain Staging cholangiocarcinoma by imaging studies HPB (Oxford) 10 2008 106 109
37. H. Ito, K. Ito, M. D'Angelica, M. Gonen, D. Klimstra, and P. Allen Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment Ann Surg 254 2011 320 325
38. K. Ito, H. Ito, P.J. Allen, M. Gonen, D. Klimstra, and M.I. D'Angelica Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma Ann Surg 251 2010 675 681
39. T. Li, L.X. Qin, J. Zhou, H.C. Sun, S.J. Qiu, and Q.H. Ye Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection Liver Int 34 2014 953 960
40. G.W. Lee, J.H. Kang, H.G. Kim, J.S. Lee, and J.S. Jang Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma Am J Clin Oncol 29 2006 127 131
41. T. Patel, and P. Singh Cholangiocarcinoma: emerging approaches to a challenging cancer Curr Opin Gastroenterol 23 2007 317 323
42. S. Kubicka, K.L. Rudolph, M.K. Tietze, M. Lorenz, and M. Manns Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas Hepatogastroenterology 48 2001 783 789
43. J.J. Knox, D. Hedley, A. Oza, R. Feld, L.L. Siu, and E. Chen Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial J Clin Oncol 23 2005 2332 2338
44. K. Yamanaka, E. Hatano, M. Kanai, S. Tanaka, K. Yamamoto, and M. Narita A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer Int J Clin Oncol 19 2014 485 489
45. R.Q. Liu, S.J. Shen, X.F. Hu, J. Liu, L.J. Chen, and X.Y. Li Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors Cancer Cell Int 13 2013 99